This week we have two papers on the eye. The first is a classic proof-of-principle paper from @masayomasayo demonstrating the application of RPE sheets to treat AMD https://t.co/kiTE0eUTar.
Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2023 – Aug 2024Where it's discussed
-
X / Twitter9 posts
-
Blogs6 articles
-
Facebook5 posts
-
Bluesky4 posts
-
News4 articles
-
YouTube2 videos
AI synopsis
What people are saying
The discussions include references to the paper as a 'classic proof-of-principle' and emphasize its importance in developing RPE cell sheets for AMD therapy, often using words like 'highlight' and 'demonstrating' to underscore its significance. The tone suggests a mix of admiration and recognition of its contribution to advancing stem cell therapies, with examples illustrating how the research aligns with long-term goals in regenerative medicine.
Most discussions recognize the significance of the study and its potential for clinical use, with some explicitly supporting its findings.
Participants show high interest, frequently emphasizing the importance of the research for treating age-related macular degeneration and noting the paper's status as a noteworthy contribution.
Posts demonstrate moderate engagement by referencing the study’s implications and placing it within the context of ongoing research milestones.
The discussions reflect an appreciation for the potential impact on medical treatments, highlighting the study's promising approach to regenerative medicine.
Abstract in brief
- The study focuses on creating retinal pigment epithelium (RPE) cell sheets derived from human induced pluripotent stem cells (hiPSCs) to treat age-related macular degeneration (AMD), which damages RPE and affects vision.
- The hiPSC-derived RPE cells are designed to meet clinical standards, forming monolayer sheets that display key RPE features like tight junctions, polarized secretion, and phagocytosis, similar to natural RPE tissue, and they show safety in nonhuman primate tests without immune rejection.
- The findings suggest that these autologous hiPSC-RPE sheets could be a promising, safe option for tissue replacement therapy in AMD patients, potentially restoring damaged retinal tissue without adverse immune responses.
Top posts
Most liked on X and BlueskyAs we continue the countdown to the @stemcellreports 10-year anniversary in June, we highlight a classic proof-of-principle paper from @masayomasayo demonstrating the application of RPE sheets to treat AMD https://t.co/3JAHK4vra0. https://t.co/mxFPHYhAYF
Editor’s top pick from the last decade of @stemcellreports: Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application @ISSCR @martinperaJAX https://t.co/zRpkp4W4UB https://t.co/BFms0MSTms
RT @stemcellreports: This week we have two papers on the eye. The first is a classic proof-of-principle paper from @masayomasayo demonstra…
RT @stemcellreports: This week we have two papers on the eye. The first is a classic proof-of-principle paper from @masayomasayo demonstra…
RT @CellPressNews: Editor’s top pick from the last decade of @stemcellreports: Characterization of human induced pluripotent stem cell-der…
All mentions
Assessment of Human iPSC-Derived Retinal Pigment Epithelium Cell Sheets for AMD Treatment
This study focuses on creating retinal pigment epithelium cell sheets from human induced pluripotent stem cells to treat age-related macular degeneration. The engineered cell sheets display key RPE features and safely…
Characterization of hiPSC-Derived Retinal Pigment Epithelium Cell Sheets for Therapy
This study focuses on creating retinal pigment epithelium cell sheets from human induced pluripotent stem cells for potential treatment of age-related macular degeneration, demonstrating their safety and functional…
Transcriptomic analysis and high throughput functional characterization of human induced pluripotent stem cell derived sensory neurons https://www.biorxiv.org/content/10.1101/2024.08.23.607310v1
Transcriptomic analysis and high throughput functional characterization of human induced pluripotent stem cell derived sensory neurons https://www.biorxiv.org/content/10.1101/2024.08.23.607310v1
Multielectrode array characterization of human induced pluripotent stem cell derived neurons in co-culture with primary human astrocytes. https://www.biorxiv.org/content/10.1101/2024.03.04.583341v1
Multielectrode array characterization of human induced pluripotent stem cell derived neurons in co-culture with primary human astrocytes. https://www.biorxiv.org/content/10.1101/2024.03.04.583341v1
RT @CellPressNews: Editor’s top pick from the last decade of @stemcellreports: Characterization of human induced pluripotent stem cell-der…
RT @CellPressNews: Editor’s top pick from the last decade of @stemcellreports: Characterization of human induced pluripotent stem cell-der…
RT @CellPressNews: Editor’s top pick from the last decade of @stemcellreports: Characterization of human induced pluripotent stem cell-der…
RT @CellPressNews: Editor’s top pick from the last decade of @stemcellreports: Characterization of human induced pluripotent stem cell-der…
Editor’s top pick from the last decade of @stemcellreports: Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application @ISSCR @martinperaJAX https://t.co/zRpkp4W4UB https://t.co/BFms0MSTms
As we continue the countdown to the @stemcellreports 10-year anniversary in June, we highlight a classic proof-of-principle paper from @masayomasayo demonstrating the application of RPE sheets to treat AMD https://t.co/3JAHK4vra0. https://t.co/mxFPHYhAYF
RT @stemcellreports: This week we have two papers on the eye. The first is a classic proof-of-principle paper from @masayomasayo demonstra…
RT @stemcellreports: This week we have two papers on the eye. The first is a classic proof-of-principle paper from @masayomasayo demonstra…
This week we have two papers on the eye. The first is a classic proof-of-principle paper from @masayomasayo demonstrating the application of RPE sheets to treat AMD https://t.co/kiTE0eUTar.
S
CP
LV
MP
P
ID
BA